retatrutide dosage weight loss clinical trial VisualAbstract: reduces body by 17.5% in patients with obesity This weight-loss drug hasn't been
Description
Gulati R, Nyame YA, Lange JM, Shoag JE, Tsodikov A, Etzioni R
They slow gastric emptying so food stays in your stomach longer, creating extended feelings of fullness while also sending signals to your brain's appetite centers to reduce hunger cravings between meals
The medications also improve how your pancreas responds to blood sugar fluctuations, reducing insulin resistancea condition that becomes more prevalent as estrogen declines
Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, for People with Type 2 Diabetes: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. The New England Journal of Medicine
otherwise these two medications are quite similar in how they work
